In general, a wider range of proteomic changes was observed in CSF from CLN1 disease mice compared to that from CLN2 disease mice, suggesting that pathology is more widely distributed in the brains of CLN1 disease mice. This evidence concerns the gene PPT1 and glycogen storage disease VI.